Breast Cancer Clinical Trial
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue
Summary
Investigation of Melody®, a lab developed test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if Melody®, can be used as a support tool in the breast cancer screening protocol for women with dense breast tissue. Melody® was designed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.
Eligibility Criteria
Inclusion Criteria:
Categorized as having heterogeneously dense or extremely dense tissue 18 years of age or older Able to understand the informed consent process Willing to comply with all study procedures
Exclusion Criteria:
Have an active eye infection Categorized as having fibro glandular densities or fatty breast tissue Currently diagnosed or are receiving treatment for breast cancer Under 18 years of age
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?